Modifying risks assessment in patients with multiple myeloma with additional fluorescence in situ hybridization (FISH) probes.
Multiple Myeloma (MM) is a disease with highly variable clinical presentation and outcome due to the complex cytogenetic aberrations involved in the disease. Much effort had been put in to identify useful prognostic markers that can stage MM patients so that appropriate treatment can be given. Howev...
Saved in:
Main Author: | Tan, Yu Min. |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/41831 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Improving detection of chromosomal abnormalities in multiple myeloma using fluorescence in situ hybridization
by: Naw, Wah Wah
Published: (2010) -
Resolving dilemma of normal cytogenetic findings in hematological disorders with fluorescence in situ hybridization (FISH) assays.
by: Ng, Yit Jun.
Published: (2010) -
Validating a new plasma cell labeling technique for targeted fluorescence in situ hybridization assay in patients diagnosed with multiple myeloma.
by: Choo, Natasha Swee Lian.
Published: (2011) -
Multiple stimulated emission fluorescence photoacoustic sensing and spectroscopy
by: Li, Gaoming, et al.
Published: (2016) -
Synthesis and characterisation of lanthanide-doped nanocrystals as fluorescence biodetection probes
by: Liu, Ji.
Published: (2010)